Figure 1: Hepatocellular carcinomas (HCC) diversify during tumour evolution, leading to multiple co-existing subtypes in a significant proportion of HCC that will require combination systemic therapies to treat the disease. (IMAGE)


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.